In the patient with newly diagnosed T2DM without micro or macrovascular complications, achieving good glycaemic control is important and this together with an eye to avoiding weight gain and hypoglycaemia will drive your choice of a second-line agent

For those at very high risk of having or those who have existing vascular disease, choosing a disease-modifying agent is important

We have to proactively avoid clinical inertia in our prescribing habits and become familiar with newer classes of agents and use them

Dr Anita Sharma gives us a clear guide as to which agent is a better choice as second and third line in particular clinical scenarios

 

 

Host: Dr David Lim | Total time: 44 mins

Guest: Dr Anita Sharma, GP and Practice Principal; Platinum Medical Centre, Chermside, QLD

 

Register for our fortnightly FREE WEBCASTS

Every second Tuesday | 7:00pm-9:00pm AEDT

Click here to register for the next one

See omnystudio.com/listener for privacy information.